Anglo/Swedish pharmaceutical giant AstraZeneca on Saturday announced a fresh shortfall in planned vaccine shipments to the European Union, citing production problems and export restrictions.
“AstraZeneca is disappointed to announce a shortfall in planned COVID-19 vaccine shipments to the European Union (EU) despite working tirelessly to accelerate supply,” it said in a statement.
The company had previously warned it was facing shortfalls from its European supply chain due to “lower-than-expected output from the production process.”
It was hoping to compensate for part of the shortfall by sourcing vaccines from its global network, with half of the EU’s supply in the second quarter and 10 million doses in the first quarter due to come from its international supply chain.
“Unfortunately, export restrictions will reduce deliveries in the first quarter, and are likely to affect deliveries in the second quarter,” it added.
AstraZeneca started delivery of the vaccine to the EU in February, and still aims to deliver 100 million doses in the first half of 2021, of which 30 million are due to be delivered in the first quarter.
The under-fire firm said it was “collaborating with the EU Commission and member states to address the supply challenges.
“It remains confident that productivity in its EU supply chain will continue to improve, to help protect millions of Europeans against the virus.”
You have reached your limit for free articles this month.
Subscription Benefits Include
Today's Paper
Find mobile-friendly version of articles from the day's newspaper in one easy-to-read list.
Unlimited Access
Enjoy reading as many articles as you wish without any limitations.
Personalised recommendations
A select list of articles that match your interests and tastes.
Faster pages
Move smoothly between articles as our pages load instantly.
Dashboard
A one-stop-shop for seeing the latest updates, and managing your preferences.
Briefing
We brief you on the latest and most important developments, three times a day.
Support Quality Journalism.
*Our Digital Subscription plans do not currently include the e-paper, crossword and print.
A letter from the Editor
Dear subscriber,
Thank you!
Your support for our journalism is invaluable. It’s a support for truth and fairness in journalism. It has helped us keep apace with events and happenings.
The Hindu has always stood for journalism that is in the public interest. At this difficult time, it becomes even more important that we have access to information that has a bearing on our health and well-being, our lives, and livelihoods. As a subscriber, you are not only a beneficiary of our work but also its enabler.
We also reiterate here the promise that our team of reporters, copy editors, fact-checkers, designers, and photographers will deliver quality journalism that stays away from vested interest and political propaganda.
Suresh Nambath
Please Email the Editor